Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
new york blog main
new york top stories
2019
activism
acute hepatic porphyria
alnylam pharmaceuticals
bernie sanders
biomarin
biotech
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
buyout
celgene
charges
clinical trials
congress
crisis
crispr
david walt
deals
detroit blog main
detroit top stories
diagnostics
drug prices
easl
fatty liver disease
feng zhang
gene editing
gene therapy
givosiran
hemophilia
What
gene
4
×
race
4
×
bio
crispr
editing
major
therapy
advanced
alnylam’s
approval
beginning
bff
close
conference
create
data
deals
devoted
diagnostic
disease
diseases
drug
easl
fix
form
forward
heated
heats
hemophilia
high
human
kicked
lap
launches
liver
marked
market
medical
medicine
medicines
Language
unset
Current search:
race
×
gene
×
@wired.com
4 months ago
Gene Editing Needs to Be for Everyone
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M